Amsterdam, Utrecht struggling with long waitlists for HIV prevention pills

Last updated 11/04/2022

At the GGD in Ams­ter­dam and Utrecht, hun­dreds of peo­ple are on the wait­list for HIV pre­ven­tion pills and some have report­ed­ly become infect­ed while wait­ing, accord­ing to AT5. The GGD is cur­rent­ly look­ing at ways to bet­ter serve patients. In Ams­ter­dam, the wait­list for the GGD’s PrEP pro­gram stretch­es […]

Now is the time! Join us. Be PrEPnu!

Last updated 04/07/2018

Now is the time! Join us. Be PrEP­nu! This month of the inter­na­tion­al AIDS con­fer­ence AIDS2018, the Pride Ams­ter­dam and (final­ly!) a gov­ern­ment deci­sion about the avail­abil­i­ty of PrEP, this is our momen­tum. PrEP­nu wants to show its face clear­ly. We hope to wel­come you, please join us. We can […]

Become a PrEP Warrior and sail with us!

Last updated 14/05/2018

Become a PrEP War­rior and sail with us! Sum­mer is fast approach­ing and our cap­i­tal city will soon be burst­ing at its seams again for Ams­ter­dam Pride, the largest LGBTQI+ event of the year. The high­light of Pride is the tra­di­tion­al boat parade along the canals, which will take place […]

Price for generic PrEP drops further to €54

Last updated 11/01/2018

Recent com­pe­ti­tion on the PrEP mar­ket has caused a fur­ther drop of the price of gener­ic PrEP in Dutch phar­ma­cies. Dis­trib­u­tor Cen­tra­farm now offers gener­ic PrEP for €47,95 (incl. VAT, plus costs). Clients will pay about €54 a month for their prod­uct. This brings PrEP with­in reach for many, if […]

Generic PrEP available in selected pharmacies for €99,50

Last updated 03/11/2017

We had to wait for a long time, but as of com­ing Mon­day, Octo­ber 30, gener­ic PrEP will be avail­able for one-sixth of the price that Phar­ma giant Gilead still charges for Tru­va­da™. With a doctor’s pre­scrip­tion you can get PrEP from San­doz in all the Plus-phar­­ma­­cies in the Nether­lands. […]

PrEPnu-consultation: a successful first

Last updated 12/07/2017

PrEP­nu had a suc­cess­ful debut with the first PrEP con­sul­ta­tion on Mon­day. Imme­di­ate­ly after the announce­ment peo­ple start­ed sign­ing up and with­in 24 hours the con­sul­ta­tion was ful­ly booked. The PrEP con­sul­ta­tion intends to help peo­ple make a respon­si­ble choice for safe use of gener­ic PrEP. Where do you buy […]

NEW! PrEPnu consultation

Last updated 08/07/2017

Next week PrEP­nu starts a week­ly PrEP con­sul­ta­tion ser­vice in the cen­tre of Ams­ter­dam. We will answer all your ques­tions about PrEP-use and gener­ic med­ica­tion. We’ll also pro­vide free HIV tests and assist you in your choice for inde­pen­dent PrEP-use. We give you friend­ly, non-judge­­men­­tal pro­fes­sion­al advice. On Mon­day 10th […]

How do you use PrEP — or are you planning to do?

Last updated 06/05/2017

Do you use PrEP cur­rent­ly? Or would you like to use PrEP? Please par­tic­i­pate in a short ques­tion­naire of Maas­tricht Uni­ver­si­ty. We are curi­ous to know your expe­ri­ences and needs! Maas­tricht Uni­ver­si­ty is the only research insti­tute in The Nether­lands that received fund­ing from the AIDS Fonds to study the […]

New PrEP-study at GGD Amsterdam

Last updated 29/08/2019

GGD Ams­ter­dam par­tic­i­pates in the large inter­na­tion­al PrEP-study DISCOVER. This study is to estab­lish the safe­ty and effec­tive­ness of the new pill F/TAF in com­par­i­son to the exist­ing PrEP pill Tru­va­da. You can apply until the 26th of March. About the DIS­­­COV­­ER-study The DIS­­­COV­­ER-study is designed by Gilead, man­u­fac­tur­er of both Tru­va­da […]

PrEP-activist health professionals launch initiative

Last updated 03/01/2017

Cheers mate! We’ll take our health in our own hands.” With a cheer­ful­ly cheeky slo­gan, last week a new group of PrEP activists intro­duced them­selves. These ‘Dutch activist health pro­fes­sion­als’ go by the some­what mil­i­tant name PrEP Tac­ti­cal Unit (PTU). Besides our com­mu­ni­ty effort PrEP­nu, there is now also a group […]

Study shows: PrEP would be cost effective in the Netherlands

Last updated 03/01/2017

Intro­duc­ing PrEP in the Nether­lands would be cost effec­tive. With a sig­nif­i­cant price reduc­tion, it could even be cost sav­ing. These two find­ings from a study that Dutch researchers from Eras­mus MC and AMC pub­lished in the Lancet Infec­tious Dis­eases should be music to the ears of the Dutch Min­is­ter […]